Measuring, managing, and improving quality in the end-stage renal disease treatment setting: committee statement.
The Institute of Medicine (IOM) committee that organized the conference reported in this issue of the journal on assessing quality of care and quality of life, wishes to emphasize that it regards the task of measuring quality as one that can be approached systematically, albeit with caution. Outcomes of end-stage renal disease (ESRD) care by dialysis and transplantation (and variations of outcomes among treatment units) and related processes of care need to be measured in ways useful to clinicians. In addition to clinical measures of outcome, the committee also favored giving greater attention to functional outcomes and health-related quality of life. The interest in maintaining and improving quality in the treatment setting reflects an underlying need to encourage its systematic assessment on a sustained basis, with appropriate weight devoted to practical issues.
Schrier
R W
RW
Institute of Medicine, National Academy of Sciences, Washington, DC 20418.
Burrows-Hudson
S
S
Diamond
L
L
Lundin
A P
AP
Michael
M
M
Patrick
D L
DL
Peters
T G
TG
Powe
N R
NR
Roberts
J S
JS
Sadler
J H
JH
D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D017063:Outcome Assessment, Health Care; D011787:Quality of Health Care / Q000458:organization & administration*; D017582:Renal Replacement Therapy / Q000592:standards*; D014481:United States